Cerus Past Earnings Performance
Past criteria checks 0/6
Cerus has been growing earnings at an average annual rate of 3.8%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 25.6% per year.
Key information
3.8%
Earnings growth rate
13.7%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 25.6% |
| Return on equity | -51.7% |
| Net Margin | -24.2% |
| Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Cerus makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 22 | 158 | -38 | 82 | 61 |
| 30 Jun 22 | 154 | -42 | 83 | 60 |
| 31 Mar 22 | 145 | -49 | 83 | 62 |
| 31 Dec 21 | 131 | -54 | 81 | 64 |
| 30 Sep 21 | 119 | -60 | 78 | 65 |
| 30 Jun 21 | 107 | -61 | 74 | 66 |
| 31 Mar 21 | 97 | -61 | 70 | 64 |
| 31 Dec 20 | 92 | -60 | 67 | 64 |
| 30 Sep 20 | 85 | -62 | 65 | 64 |
| 30 Jun 20 | 79 | -66 | 65 | 64 |
| 31 Mar 20 | 76 | -69 | 66 | 63 |
| 31 Dec 19 | 75 | -71 | 66 | 60 |
| 30 Sep 19 | 70 | -71 | 64 | 56 |
| 30 Jun 19 | 68 | -67 | 62 | 51 |
| 31 Mar 19 | 65 | -62 | 59 | 47 |
| 31 Dec 18 | 61 | -58 | 57 | 43 |
| 30 Sep 18 | 61 | -53 | 55 | 38 |
| 30 Jun 18 | 56 | -52 | 53 | 35 |
| 31 Mar 18 | 50 | -56 | 53 | 34 |
| 31 Dec 17 | 44 | -61 | 53 | 34 |
| 30 Sep 17 | 37 | -63 | 52 | 35 |
| 30 Jun 17 | 37 | -64 | 52 | 34 |
| 31 Mar 17 | 37 | -65 | 51 | 34 |
| 31 Dec 16 | 37 | -63 | 49 | 31 |
| 30 Sep 16 | 37 | -64 | 48 | 30 |
| 30 Jun 16 | 35 | -65 | 46 | 30 |
| 31 Mar 16 | 34 | -63 | 46 | 27 |
| 31 Dec 15 | 34 | -56 | 46 | 26 |
Quality Earnings: CU2 is currently unprofitable.
Growing Profit Margin: CU2 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CU2 is unprofitable, but has reduced losses over the past 5 years at a rate of 3.8% per year.
Accelerating Growth: Unable to compare CU2's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CU2 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: CU2 has a negative Return on Equity (-51.73%), as it is currently unprofitable.